TrialJournal for immunotherapy of cancer2026

Efficacy and safety of pembrolizumab, lenvatinib, and reduced-dose gemcitabine/oxaliplatin as initial treatment for advanced biliary tract cancer: a multicenter, single-arm, prospective, phase II study.

Mingjian Piao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.